Morgan Stanley Examines HCA Holdings' Initial FY14 Guidance

Loading...
Loading...
In a report published Wednesday, Morgan Stanley analyst Andrew Schenker reiterated an Overweight rating and $55.00 price target on
HCA HoldingsHCA
. In the report, Morgan Stanley noted, “HCA issued initial FY14 guidance including reform benefit. While the high end of guidance came in above consensus, it is below our estimate of $6.94B. Upside in our model is primarily based on a higher reform benefit of 4% of adj. EBITDA vs. guidance of 1% to 2%.” HCA Holdings closed on Tuesday at $48.52.
date
ticker
name
Price Target
Upside/Downside
Recommendation
Firm
Posted In: Analyst ColorReiterationAnalyst RatingsAndrew SchenkerMorgan Stanley
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!

Loading...